Genito Urinary Translational Study (GUTS) Group
The goal of this forum is to promote the discussion of state-of-the-art research in genito-urinary medicine, with the goal of expanding basic, clinical, and translational research and training at MMC.
Next up on G.U.T.S:
"FOXD1 in renal cell carcinoma"
Presenters: Jen Fetting, Ivette Emery, Christine Duarte
7 am, Date: July 31, 2014
Dana 9, MMC
FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidney. Fetting JL, Guay JA, Karolak MJ, Iozzo RV, Adams DC, Maridas DE, Brown AC, Oxburgh L. Development. 2014 Jan;141(1):17-27. doi: 10.1242/dev.089078. Epub 2013 Nov 27.
Recent Interesting Studies or Reviews:
Significance of androgen receptor variants in castration resistant prostate cancer. Ware KE, Garcia-Blanco MA, Armstrong AJ, Dehm S. Endocr Relat Cancer. 2014 May 23. pii: ERC-13-0470. [Epub ahead of print]
Recent MMC/MMCRI Cancer-Related Studies:
Breast Cancer Knowledge, Beliefs, and Screening Practices among Women Seeking Care at District Hospitals in Dar es Salaam, Tanzania. Morse EP, Maegga B, Joseph G, Miesfeldt S.
Breast Cancer (Auckl). 2014 May 8;8:73-9.
Cryptic collagen IV promotes cell migration and adhesion in myeloid leukemia. Favreau AJ, Vary CP, Brooks PC, Sathyanarayana P. Cancer Med. 2014 Apr;3(2):265-72. doi: 10.1002/cam4.203. Epub 2014 Feb 12.
Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia. Duarte CW, Murray K, Lucas FL, Fairfield K, Miller H, Brooks P, Vary CP. Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):117-25.